4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
Alzheimer's Association International Conference 2026
July 12-15, 2026 | London, United Kingdom, and Online
Posters by Session
3707
BACE1 Inhibitors Versus Placebo In The Treatment Of Alzheimer’s Disease: A Meta Analysis
Harish Sidharth Veerachamy
Barking Havering and Redbridge NHS Trust
Poster Presenter: Harish Sidharth Veerachamy
4709
Real-world Safety And Cognitive Outcomes Of Lecanemab: One-year Experience From A Korean Memory Clinic
Sanghyuk Lee
Poster Presenter: Sanghyuk Lee
5938
The Oral P38a Kinase Inhibitor Neflamapimod Slows The Rate Of Clinical Worsening In Dementia With Lewy Bodies (DLB)
John-Paul Taylor, John Alam, Stephen N. Gomperts, Lawrence Honig, Niels Prins, Hui-May Chu, Amanda Gardner, Kelly Blackburn, Charlotte Teunissen, James Galvin
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA, Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle, United Kin...
Poster Presenter: John-Paul Taylor
2617
Anti-amyloid Immunotherapies In Alzheimer’S Disease: Are Future Prescribers Prepared? Insights Of A French National Survey.
Karl Götze
Geriatric daily hospital, Hôpital Bretonneau, GHU APHP.Nord, Université Paris Cité.
Poster Presenter: Karl Gφtze
277
Screening For Eligibility In A Preclinical AD Trial: Effect Of Testing In A Non-primary Language.
Valerie Tung, David Sultzer, Maria Corona, Katharine Kirby, Joshua Grill
null,
Poster Presenter: Valerie Tung
1577
KHN923: A Bispecific Antibody With TfR-mediated CNS Delivery And Potent aί Clearance Efficacy
Menglong Guan, Pengfei Ren, Xiaoyu Wang, Ju Yue, Zhengping Li, Gang Lei, Yanhua Xu, Xiao Ke, Yonghao Zhao
null
Poster Presenter: Yonghao Zhao
5402
Expanding Clinical Trial Access To Underrepresented Populations In The U.S.: Findings From The Alzheimer’s Disease Pre-screener Study
Luisa Guglielmini
Poster Presenter: Luisa Guglielmini
4508
Screening And Baseline Characteristics Of A Ph2b/3 Randomized, Placebo-Controlled Trial Of Emestedastat In Mild/Moderate AD
Jack Taylor, Paul Rolan, Mark Jaros, Michael Woodward, Christopher Chen, Dana Hilt
Actinogen Medical, University of Adelaide Medical School, South Australia, Australia, Summit Analytical, Chicago, USA, Austin Health, Melbourne, VIC, Australia, Memory Ageing and Cognition Centre, National Univ...
Poster Presenter: Jack Taylor
4637
Applying Bayesian Model Averaging For Modelling Longitudinal Treatment Effects Within Alzheimer's Disease Clinical Trials
Ben Jones, Ashwini Venkatsubramaniam, Doug Thompson, Dave Lunn, Aris Perperoglou, Dave Inman
Department of Biostatistics, GSK, Quantitative Sciences Innovation, GSK
Poster Presenter: Benjamin Jones